We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

69 hedge funds and large institutions have $284M invested in Cogent Biosciences in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 11

2.06% more ownership

Funds ownership: 92.68% → 94.74% (+2.1%)

0% more funds holding

Funds holding: 69 → 69 (0)

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

6% less capital invested

Capital invested by funds: $303M → $284M (-$19.4M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
69
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
19
Increased
18
Reduced
11
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$17.8M
2
CS
Candriam SCA
Luxembourg
+$12.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.36M
4
DM
Deerfield Management
New York
+$5.08M
5
State Street
State Street
Massachusetts
+$4.11M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$11.1M
2
Millennium Management
Millennium Management
New York
-$6.73M
3
SFM
Sphera Funds Management
Israel
-$6.7M
4
DCM
Driehaus Capital Management
Illinois
-$4.96M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$4.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
NLVP
26
New Leaf Venture Partners
New York
$2.66M – – –
SSA
27
Schonfeld Strategic Advisors
New York
$2.22M +$583K +68,990 +34%
Citigroup
28
Citigroup
New York
$2.06M -$328K -38,851 -13%
DCM
29
DAFNA Capital Management
California
$1.81M – – –
JP Morgan Chase
30
JP Morgan Chase
New York
$1.37M -$667K -78,947 -32%
N
31
Nuveen
North Carolina
$1.05M +$1.1M +129,850 New
AA
32
AlphaCentric Advisors
Puerto Rico
$993K +$275K +32,500 +36%
MCM
33
Moore Capital Management
New York
$988K -$15.7K -1,861 -2%
Charles Schwab
34
Charles Schwab
California
$762K +$794K +93,951 New
Qube Research & Technologies (QRT)
35
Qube Research & Technologies (QRT)
United Kingdom
$451K +$55.3K +6,546 +13%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$416K +$433K +51,309 New
V
37
Veritable
Delaware
$404K +$336K +39,799 +396%
IC
38
Ikarian Capital
Texas
$338K – – –
BCM
39
Bridgeway Capital Management
Texas
$322K -$70.8K -8,379 -17%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$310K +$323K +38,280 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$258K +$269K +31,800 New
SAM
42
Sectoral Asset Management
Quebec, Canada
$219K – – –
VEA
43
Virtus ETF Advisers
New York
$199K -$30K -3,547 -13%
Jane Street
44
Jane Street
New York
$196K +$204K +24,192 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$188K +$196K +23,235 New
QSS
46
Quantitative Systematic Strategies
Florida
$182K -$214K -25,287 -53%
Deutsche Bank
47
Deutsche Bank
Germany
$179K +$186K +22,060 New
WC
48
Wexford Capital
Florida
$162K – – –
Bank of America
49
Bank of America
North Carolina
$142K -$64.4K -7,620 -30%
LPL Financial
50
LPL Financial
California
$122K +$33.8K +4,000 +36%
1
2
3 4

COGT Hedge Fund Activity: Q2 2021 in Review

69 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q2 2021, worth a combined $284M — down 6.4% from $303M a quarter earlier.

Fund positioning in COGT was balanced in Q2 2021: 19 funds opened new positions, 19 closed out, 18 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $17.8M. The largest seller was Citadel Advisors, exiting entirely with an estimated $11.1M sold.

  • 69 institutional investors held Cogent Biosciences (COGT) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $284M of Cogent Biosciences stock for Q2 2021, down 6.4% quarter-over-quarter.
  • 19 funds opened new Cogent Biosciences positions in Q2 2021 and 19 closed out, a net change of 0 holders.
  • The largest Cogent Biosciences buyer in Q2 2021 was BlackRock, an estimated $17.8M added.
  • The largest Cogent Biosciences seller in Q2 2021 was Citadel Advisors, an estimated $11.1M sold.

Based on aggregated 13F filings for Q2 2021.